Correction to: Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma

Abstract

In the published article (Wadhwani et al., 2018) the statement under the subheading 'Consent for publication' is incorrect. "Case reports are exempt from the purview of our institutional health research ethics board and therefore no approval is required from the ethics board for publication." should read: "Informed consent for publication of this case report and its accompanying images has been obtained from the patient".

BCG mycotic aneurysm: Case report on a rare entity

“…There is some evidence to show that EVAR offers superior short term survival as compared to open surgical resection (OSR). 5 Infection related complications are more frequent with EVAR, with a recent multicenter study of 120 MAA managed with EVAR demonstrating 5% risk of subsequent OSR, 27% risk of infection related complications, and a 41% survival rate over a 5-year follow up period. 4 …”

“… 4 Existing atherosclerotic plaques and aneurysm/pseudoaneurysm also increases the risk of developing MAA with treatment. 5 Contraindications of intravesical BCG therapy should also be adhered to so as to reduce risk of BCGosis and MAA.…”